Articles

$ ZOSANO..... vive hausse pour cause

Biogen and AbbVie Announce the Voluntary Worldwide Withdrawal of Marketing Authorizations for ZINBRYTA® (daclizumab) for Relapsing Multiple Sclerosis | Business Wire

FDA

Reata Announces Top-Line Data from the Dose-Escalation Cohorts of the Phase 2 Motor Study of Omaveloxolone in Patients With Mitochondrial Myopathies

$ PAIN THERAPEUTICS

TARKETT

Recommandations

MERCI pour vôtre contribution

PHILIPS&HOLOGIC

Cardiovascular Systems, Inc. and OrbusNeich Announce FDA Clearance of the First and Only 1.0mm Coronary Balloon in the U.S. | Business Wire

Synergy Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Business Update | Business Wire